Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
904.97
-1.21 (-0.13%)
Official Closing Price
Updated: 6:30 PM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
98
99
Next >
Why ResMed Stock Tumbled by 5% Today
Today 17:49 EDT
A looming threat from a very powerful rival could significantly dampen a key business for the company.
Via
The Motley Fool
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
Today 10:07 EDT
Terns has a modest market cap of less than $800 million, and its possible upside could be massive.
Via
The Motley Fool
ADX: A High-Yielding, Diversified CEF Worth Looking Into
Today 1:47 EDT
When it comes to investing, there are two critical “bedrocks” we need to keep in mind. These two facts are why 95% of my favorite high-income investments, closed-end funds (CEFs), have made investors...
Via
Talk Markets
Looking Into Eli Lilly's Recent Short Interest
September 17, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
September 17, 2024
Via
Benzinga
Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar Club
September 17, 2024
Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the door of a trillion-dollar valuation.
Via
The Motley Fool
6 Incredible Reasons to Invest in Eli Lilly
September 13, 2024
The drug giant's winning ways look set to continue for a while.
Via
The Motley Fool
Looking At Eli Lilly's Recent Unusual Options Activity
September 12, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
September 12, 2024
Via
Benzinga
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
Telemedicine once seemed like it was going to revolutionize healthcare.
Via
The Motley Fool
Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss
September 16, 2024
The FDA has approved Eli Lilly's Ebglyss for moderate-to-severe eczema in patients 12 and older. The treatment is administered via monthly injections and demonstrated clear skin and itch relief in...
Via
Benzinga
Exposures
Product Safety
3 Stocks to Buy and Hold Forever
September 14, 2024
These stocks are built for the long run.
Via
The Motley Fool
Time To Invest And Or Trade In Bio-Tech Stocks?
September 13, 2024
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help...
Via
Talk Markets
Topics
ETFs
Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review
September 13, 2024
The major indexes reclaimed key levels and many leaders flashed buy signals.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years
September 10, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Eli Lilly Through 28 Analysts
September 09, 2024
Via
Benzinga
Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound
September 12, 2024
The investment is aimed at ensuring a steady supply of the drugs, which have been grappling with shortages since 2022.
Via
Benzinga
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
September 12, 2024
Amgen is a decently valued stock that has an excellent business and also gives investors a way to potentially gain exposure to a lucrative weight loss market.
Via
The Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
An investment in these players today could score a big win down the road.
Via
The Motley Fool
Why Roche Holdings Stock Withered on Wednesday
September 11, 2024
The company had a dispiriting update to offer about an investigational drug.
Via
The Motley Fool
Why Viking Therapeutics Stock Rocked the Market Today
September 11, 2024
The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug.
Via
The Motley Fool
4 No-Brainer Stock Splits to Buy Now
September 11, 2024
There's a massive reason these stocks should split now.
Via
The Motley Fool
Could Elon Musk Become The World's First Trillionaire? Tesla's Success Could Make It Happen As Early As...
September 11, 2024
A new study predicts Elon Musk will become the world's first trillionaire if Tesla can regain the $1 trillion market cap level.
Via
Benzinga
Novo Nordisk Jumps After New Weight-Loss Pill Tops Wegovy; Eli Lilly, Viking Shares Rise
September 11, 2024
The company is working on a drug that targets GLP-1 and amylin to improve weight loss.
Via
Investor's Business Daily
Ozempic Maker Novo Nordisk Touts Encouraging Data From New Obesity Pill Showing Double Weight Loss Compared To Wegovy
September 11, 2024
Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight loss in three months with adult participants.
Via
Benzinga
Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)
September 11, 2024
There's a little appreciated reason to own Eli Lilly stock, and it has nothing to do with its medicines.
Via
The Motley Fool
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
Telemedicine was one of the most in-demand services during the height of the COVID-19 pandemic.
Via
The Motley Fool
Exposures
COVID-19
Prediction: These 2 Companies Will Split Their Stocks by 2027
September 11, 2024
Eli Lilly and Regeneron Pharmaceuticals are good stock-split candidates thanks to years of successes.
Via
The Motley Fool
Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval
September 11, 2024
Novo Nordisk has announced that its weight-loss drug liraglutide is safe and effective for children as young as six. The company-funded study revealed a 7.4% reduction in body-mass index for children...
Via
Benzinga
Exposures
Product Safety
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
September 09, 2024
Eli Lilly and Company has appointed Lucas Montarce as executive vice president and chief financial officer, effective immediately.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
98
99
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.